Find similar products:
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL 25258/0353.
Sitagliptin 50 mg/2 ml oral solution
Sitagliptin 50 mg/2 ml oral solution
sitagliptin
1. What Sitagliptin oral solution is and what it is used for
2. What you need to know before you take Sitagliptin oral solution
3. How to take Sitagliptin oral solution
4. Possible side effects
5. How to store Sitagliptin oral solution
6. Contents of the pack and other information
Sitagliptin oral solution contains the active substance sitagliptin which is a member of a class of medicines called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus.
This medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body.
Your doctor or prescriber has prescribed this medicine to help lower your blood sugar, which is too high because of your type 2 diabetes. This medicine can be used alone or in combination with certain other medicines (insulin, metformin, sulphonylureas, or glitazones) that lower blood sugar, which you may already be taking for your diabetes together with a food and exercise plan.
What is type 2 diabetes?
Type 2 diabetes is a condition in which your body does not make enough insulin, and the insulin that your body produces does not work as well as it should. Your body can also make too much sugar.
When this happens, sugar (glucose) builds up in the blood. This can lead to serious medical problems like heart disease, kidney disease, blindness, and amputation.
Cases of inflammation of the pancreas (pancreatitis) have been reported in patients receiving Sitagliptin oral solution (see section 4).
If you encounter blistering of the skin it may be a sign for a condition called bullous pemphigoid. Your doctor or prescriber may ask you to stop Sitagliptin oral solution.
Tell your doctor or prescriber if you have or have had:
This medicine is unlikely to cause low blood sugar because it does not work when your blood sugar is low. However, when this medicine is used in combination with a sulphonylurea medicine or with insulin, low blood sugar (hypoglycaemia) can occur. Your doctor or prescriber may reduce the dose of your sulphonylurea or insulin medicine.
Children and adolescents below 18 years should not use this medicine. It is not effective in children and adolescents between the ages of 10 and 17 years. It is not known if this medicine is safe and effective when used in children and adolescents under 10 years.
Tell your doctor or prescriber, or pharmacist if you are taking, have recently taken or might take any other medicines.
In particular, tell your doctor or prescriber if you are taking digoxin (a medicine used to treat irregular heart beat and other heart problems). The level of digoxin in your blood may need to be checked if taking with Sitagliptin oral solution.
Sitagliptin oral solution can be taken with or without food.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or prescriber, or pharmacist for advice before taking this medicine.
You should not take this medicine during pregnancy.
It is not known if this medicine passes into breast milk. You should not take this medicine if you are breast-feeding or plan to breast-feed.
This medicine has little or no effect on the ability to drive and use machines. However, dizziness and drowsiness have been reported, which may affect your ability to drive or use machines.
Taking this medicine in combination with medicines called sulphonylureas or with insulin can cause hypoglycaemia, which may affect your ability to drive and use machines.
Sitagliptin oral solution contains sodium methyl parahydroxybenzoate (E219):
This may cause allergic reactions (possibly delayed).
This medicine contains less than 1 mmol sodium (23mg) per 2 ml, that is to say essentially ‘sodium free’.
Always take this medicine exactly as your doctor or prescriber has told you. Check with your doctor or prescriber, or pharmacist if you are not sure.
The usual recommended dose is:
If you have kidney problems, your doctor or prescriber may prescribe lower doses (such as 25 mg or 50 mg).
Your doctor or prescriber may prescribe this medicine alone or with certain other medicines that lower blood sugar.
Diet and exercise can help your body use its blood sugar better. It is important to stay on the diet and exercise recommended by your doctor or prescriber while taking Sitagliptin oral solution.
Please use the oral syringe provided to deliver your specific dose – see instructions below. The syringe can be used to measure your dose by drawing the liquid to the correct mark on the syringe.
1. Shake the bottle well, making sure the cap is firmly on the bottle.
2. Remove the cap.
Note: Keep the cap nearby to close the bottle after each use.
3. Make sure that the plastic adapter is into the neck of the bottle.
Note: The adapter must always stay in the bottle.
4. Take the syringe and check the plunger is fully down.
5. Keep the bottle upright and insert the oral syringe firmly into the plastic adapter.
6. Turn the whole bottle with the syringe upside down.
7. Slowly pull the plunger down fully so that the syringe fills with medicine. Push the plunger back up completely to expel any large air bubbles that may be trapped inside the oral syringe.
8. Then pull the plunger slowly back to the volume you need for your dose.
9. Turn the whole bottle with the syringe the right way up and take the syringe out of the bottle.
10. The dose of medicine can now be swallowed directly from the oral syringe. Please ensure that you are sitting upright, and the plunger must be pushed slowly to allow you to swallow the dose.
11. Replace the child resistant cap after use, leaving the adapter in place.
12. Cleaning: After use, dismantle the plunger and rinse both body and plunger with tap water and wipe with a dry, clean tissue or paper.
If you take more than the prescribed dosage of this medicine, contact your doctor or prescriber immediately.
If you miss a dose, take it as soon as you remember. If you do not remember until it is time for your next dose, skip the missed dose and go back to your regular schedule. Do not take a double dose of this medicine.
Continue to take this medicine as long as your doctor or prescriber prescribes it so you can continue to help control your blood sugar. You should not stop taking this medicine without talking to your doctor or prescriber first.
If you have any further questions on the use of this medicine, ask your doctor or prescriber, or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
STOP taking Sitagliptin oral solution and contact a doctor or prescriber immediately if you notice any of the following serious side effects:
If you have a serious allergic reaction (frequency not known), including rash, hives, blisters on the skin/peeling skin and swelling of the face, lips, tongue, and throat that may cause difficulty in breathing or swallowing, stop taking this medicine and call your doctor or prescriber right away. Your doctor or prescriber may prescribe a medicine to treat your allergic reaction and a different medicine for your diabetes.
Some patients have experienced the following side effects after adding sitagliptin to metformin:
Common (may affect up to 1 in 10 people): low blood sugar, nausea, flatulence, vomiting
Uncommon (may affect up to 1 in 100 people): stomach ache, diarrhoea, constipation, drowsiness
Some patients have experienced different types of stomach discomfort when starting the combination of sitagliptin and metformin together (frequency is common).
Some patients have experienced the following side effects while taking sitagliptin in combination with a sulphonylurea and metformin:
Very common (may affect more than 1 in 10 people): low blood sugar
Common: constipation
Some patients have experienced the following side effects while taking sitagliptin and pioglitazone:
Common: flatulence, swelling of the hands or legs
Some patients have experienced the following side effects while taking sitagliptin in combination with pioglitazone and metformin:
Common: swelling of the hands or legs
Some patients have experienced the following side effects while taking sitagliptin in combination with insulin (with or without metformin):
Common: flu-like symptoms
Uncommon: dry mouth
Some patients have experienced the following side effects while taking sitagliptin alone in clinical studies, or during post-approval use alone and/or with other diabetes medicines:
Common: low blood sugar, headache, upper respiratory infection, stuffy or runny nose and sore throat, osteoarthritis, arm or leg pain
Uncommon: dizziness, constipation, itching
Rare: reduced number of platelets
Frequency not known: kidney problems (sometimes requiring dialysis), vomiting, joint pain, muscle pain, back pain, interstitial lung disease, bullous pemphigoid (a type of skin blister)
If you get any side effects, talk to your doctor or prescriber, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label and the carton after ‘EXP’.
The expiry date refers to the last day of that month.
Store in a refrigerator (2°C to 8°C).
After first opening of the bottle, the solution can be stored for 90 days.
Discard any remaining medicine 90 days after opening the bottle.
Do not throw away medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is sitagliptin. Each 2ml of oral solution contains sitagliptin hydrochloride monohydrate, equivalent to 50mg sitagliptin.
The other ingredients are:
Sodium methyl parahydroxybenzoate (E219), hydroxyethylcellulose (E1525), citric acid (E330), disodium edetate (E330), polysorbate 80 (E433), butyl hydroxy anisole (E320), sodium citrate (E331), polisucra 7477 (containing sucralose (E955), acesulfame), forest fruits flavor (consisting of maltodextrin (E1400), modified starch (E1400-E1500), lactic acid (E270), benzyl alcohol (E1519), ethyl alcohol (E1510), ethyl butyrate, frambinon crystal, propyleneglycol (E1520)), purified water.
The Sitagliptin oral solution appears as an amber glass bottle with cap.
Carton folded box contains one capped glass bottle with l00 ml oral solution, one 5ml medication syringe (applicator, CE marked CE 0459) with 0.5ml graduation.
This leaflet was last revised in September 2024